Research Alliance Corp III
RACCHeld by 4 specialist biotech funds
High Convergence4 funds opened new positions. Short interest: 0.1% of float.
Research Alliance Corporation III functions as a blank check company, also referred to as a Special Purpose Acquisition Company (SPAC). Its primary objective is to complete a business combination, which might take the form of a merger, an equity exchange, an acquisition of assets or stock, or a corporate reorganization, with one or more other companies. The firm was established on February 19, 2026, and its main offices are located in New York, NY.